• Most Popular
  • Most Shared

Global Deals Review: Q4 2009

Two men shakes hands in this file photo. REUTERS/Files

Hot sectors in a tepid recovery

The energy, finance, technology and healthcare industries are expected to be the hottest areas for dealmaking in 2010.   Full Article | Full Coverage 

» More Global Deals Review: Q4 2009 News

Ranbaxy shares up 3 percent on Pfizer may bid report

MUMBAI
Fri Jun 13, 2008 4:06am EDT

MUMBAI (Reuters) - Shares in Ranbaxy Laboratories Ltd rose more than 3 percent early on Friday after a newspaper said Pfizer Inc may bid for the Indian drug maker, countering a $4.6 billion offer by Japan's Daiichi Sankyo Co Ltd.

Health  |  Deals  |  Hot Stocks

Ranbaxy shares rose as much as 3.6 percent to 561.75 rupees in Mumbai market that was up 0.2 percent.

Pfizer, the world's largest drug maker, may bid for the about 65 percent of Ranbaxy held by institutions and public shareholders, the Business Standard newspaper reported citing unidentified sources familiar with the development.

(Reporting by Hiral Vora; Editing by Ranjit Gangadharan)
Health
Deals
Hot Stocks


More from Reuters

Photo

New home sales hit seven-month low

WASHINGTON (Reuters) - Consumer spending rose for a second straight month in November as incomes recorded their biggest gain in six months, but a surprise drop in new home sales was a reminder that the economic recovery would be bumpy.

» More Top News
A glass of water taken from a residential well after the start of natural gas drilling in Dimock, Pennsylvania, March 7, 2009. Dimock is one of hundreds of sites in Pennsylvania where energy companies are now racing to tap the massive Marcellus Shale natural gas formation. REUTERS/Tim Shaffer

Not in my watershed: NYC

The biggest U.S. city wants the state to ban one of the most promising sources of U.S. energy -- and also one of the most contentious.  Full Article 

Green Business
Cannabis sativa plant is seen in Buenos Aires, August 21, 2009. REUTERS/Enrique Marcarian
Bernd Debusmann:

Obama, drugs, common sense

American attitudes towards drug prohibition – and above all, punitive laws on marijuana – are changing too fast for policymakers and legislators to ignore.  Commentary 

U.S.